Infinimmune, Merck enter into antibody discovery pact

Merck will have the exclusive right to develop and commercialize antibody candidates that come out of the collaboration. Infinimmune said it will use its proprietary platform to screen large numbers of human immune cells and identify naturally occurring antibodies, then use AI tools to refine and improve them. The companies did not disclose the disease targets Merck selected for the partnership. Infinimmune, Merck enter into antibody discovery pact | Reuters Exclusive news, data and analytics for financial ...